Bloomin Brands
BLMN
8.39
+0.22
+2.69%
Bloomin Brands
US · BLMN
#3512 by market cap
8.39
+0.22
+2.69%
Live - 5344 symbols - heartbeat 238s ago
· 2026-10-08 10:09
Pre-market
8.08
-1.10%
After-hours
8.16
-0.12%
Overnight
8.10
-0.86%
- Market cap
- 718.36M
- P/E (TTM)i
- 26.22
- P/Bi
- 1.66
- EPSi
- 0.10
- Div yieldi
- 1.79%
- 52W posi
- 43%
Reader sentiment
Are you bullish or bearish on BLMN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.88, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +0.14% YoY
Margins
- Gross margin
- 13.31%
- Operating margin
- 2.79%
- Net margin
- 0.21%
Key ratios & quality
- Enterprise valuei
- 1.62B
- Altman Z-Scorei
- 0.88
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.13B | 4.14B | 3.17B | 4.12B | 4.01B | 4.17B | 3.95B | 3.96B |
| Gross profit | 666.43M | 672.23M | 336.00M | 731.70M | 674.88M | 719.17M | 599.06M | 526.56M |
| Selling & admin expenses | 282.72M | 275.24M | 254.36M | 245.62M | 212.93M | 233.56M | 219.38M | 238.40M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 182.12M | 200.18M | -98.62M | 322.70M | 312.05M | 316.34M | 204.10M | 110.49M |
| Pretax profit | 100.31M | 141.69M | -239.52M | 249.30M | 127.40M | 231.19M | -58.81M | -8.19M |
| Tax | -9.23M | 7.57M | -80.73M | 26.38M | 34.25M | 18.40M | -12.13M | -26.70M |
| Net profit | 109.54M | 134.12M | -158.80M | 222.91M | 109.20M | 254.41M | -122.66M | 13.23M |
| Basic EPS | 1 | 1 | -2 | 2 | 1 | 3 | -1 | 0 |
| Diluted EPS | 1.14 | 1.45 | -1.85 | 2.00 | 1.03 | 2.56 | -1.49 | 0.10 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.05B | 1.00B | 928.81M | 975.22M | 1.06B | 1.02B |
| Gross profit | 162.91M | 135.32M | 100.87M | 127.48M | 163.24M | 141.91M |
| Selling & admin expenses | 61.38M | 59.53M | 59.10M | 58.39M | 52.31M | 53.66M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 57.58M | 31.19M | -3.18M | 24.90M | 64.64M | 42.24M |
| Pretax profit | 46.04M | 18.95M | -47.53M | -25.65M | 46.69M | 27.12M |
| Tax | 903.00K | -8.75M | -2.40M | -16.45M | -10.29M | -6.67M |
| Net profit | 43.60M | 26.67M | -45.28M | -11.76M | 57.24M | 32.58M |
| Basic EPS | 1 | 0 | -1 | 0 | 1 | 0 |
| Diluted EPS | 0.50 | 0.30 | -0.54 | -0.16 | 0.65 | 0.36 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 335.48M | 340.47M | 323.85M | 352.79M | 346.58M | 343.31M | 320.52M | 269.64M |
| Cash & ST investments | 71.82M | 67.15M | 109.98M | 87.59M | 84.74M | 111.52M | 70.06M | 59.46M |
| Inventory | 72.81M | 86.86M | 61.93M | 79.11M | 78.12M | 62.95M | 68.70M | 61.49M |
| Total assets | 2.46B | 3.59B | 3.36B | 3.29B | 3.32B | 3.42B | 3.38B | 3.17B |
| Total current liabilities | 791.04M | 962.02M | 950.10M | 984.63M | 978.87M | 1.00B | 952.34M | 878.65M |
| Short-term debt | 27.19M | 26.41M | 38.71M | 10.96M | 183.51M | 163.72M | 158.81M | 176.27M |
| Long-term debt | 1.07B | 1.02B | 997.77M | 782.11M | 828.51M | 780.72M | 1.03B | 787.43M |
| Total liabilities | 2,409,957,000.00 | 3,415,202,000.00 | 3,351,150,000.00 | 3,071,421,000.00 | 3,046,516,000.00 | 3,012,078,000.00 | 3,245,359,000.00 | 2,834,742,000.00 |
| Total equity | 54.82M | 177.48M | 10.96M | 222.85M | 273.91M | 412.00M | 139.45M | 337.17M |
| Retained earnings | -920.01M | -755.09M | -918.10M | -698.17M | -706.11M | -528.83M | -925.83M | -917.60M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 318.88M | 331.96M | 351.25M | 269.64M | 208.80M | 209.59M |
| Cash & ST investments | 57.69M | 50.31M | 66.48M | 59.46M | 71.30M | 66.61M |
| Inventory | 60.57M | 57.15M | 59.18M | 61.49M | 53.20M | 60.31M |
| Total assets | 3.31B | 3.31B | 3.28B | 3.17B | 3.11B | 3.12B |
| Total current liabilities | 778.47M | 777.20M | 774.42M | 878.65M | 799.88M | 824.04M |
| Short-term debt | 161.19M | 162.51M | 176.25M | 176.27M | 177.05M | 176.82M |
| Long-term debt | 917.61M | 917.07M | 962.25M | 787.43M | 752.61M | 702.79M |
| Total liabilities | 2,920,520,000.00 | 2,906,254,000.00 | 2,932,056,000.00 | 2,834,742,000.00 | 2,715,665,000.00 | 2,682,987,000.00 |
| Total equity | 384.85M | 401.29M | 348.01M | 337.17M | 398.77M | 435.07M |
| Retained earnings | -883.68M | -858.26M | -904.12M | -917.60M | -861.94M | -830.60M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 288.07M | 317.60M | 138.85M | 402.46M | 390.92M | 532.42M | 228.13M | 276.69M |
| Depreciation & amortization | 201.59M | 196.81M | 180.26M | 163.39M | 149.90M | 169.27M | 175.58M | 177.68M |
| Free cash flow | 79.85M | 155.68M | 51.01M | 279.63M | 198.13M | 250.19M | 7.40M | 96.77M |
| Dividends paid | -33.31M | -35.73M | -17.48M | 0 | -49.74M | -83.74M | -82.57M | -38.27M |
| Stock buybacks / issuance | -113.97M | -106.99M | 0 | 0 | -109.15M | -70.85M | -265.70M | 0 |
| Ending cash balance | 71.82M | 67.15M | 110.41M | 89.06M | 84.74M | 114.37M | 70.06M | 59.46M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 73.47M | 49.66M | 34.43M | 119.14M | 75.30M | 90.92M |
| Depreciation & amortization | 43.95M | 44.60M | 44.95M | 44.19M | 46.30M | 46.01M |
| Free cash flow | 27.69M | 11.14M | -5.73M | 63.67M | 50.12M | 46.91M |
| Dividends paid | -12.75M | -12.76M | -12.76M | 0 | 0 | 0 |
| Stock buybacks / issuance | -- | -- | -- | 0 | -- | -- |
| Ending cash balance | 57.69M | 50.31M | 66.48M | 59.46M | 71.30M | 66.61M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 254.05 | 120.86 | -185.93 | 195.42 | 41.78 | 72.71 | -47.01 | 3.51 |
| ROA %i | 4.25 | 4.31 | -4.66 | 6.48 | 3.08 | 7.34 | -3.76 | 0.25 |
| ROIC %i | 12.18 | 9.74 | -5.02 | 12.01 | 6.31 | 12.46 | -3.19 | 1.77 |
| 5-year avg ROE %i | 64.43 | 85.06 | 42.57 | 79.05 | 71.40 | 49.03 | 15.46 | 53.34 |
| EBIT margin %i | 3.52 | 4.61 | -5.52 | 7.45 | 4.64 | 6.96 | 0.10 | 0.94 |
| FCF / sales %i | 1.94 | 3.76 | 1.61 | 6.78 | 3.88 | 4.46 | 0.19 | 2.45 |
| Current ratioi | 0.42 | 0.35 | 0.34 | 0.36 | 0.35 | 0.34 | 0.34 | 0.31 |
| Quick ratioi | 0.25 | 0.22 | 0.22 | 0.21 | 0.22 | 0.20 | 0.19 | 0.18 |
| Debt / assetsi | 44.42 | 64.79 | 67.05 | 59.88 | 65.07 | 59.34 | 67.20 | 63.37 |
| LT debt / equityi | 2,334.54 | 1,351.01 | 53,454.55 | 906.19 | 728.57 | 456.61 | 1,561.45 | 549.70 |
| Interest coveragei | 3.23 | 3.88 | -2.72 | 5.33 | 3.86 | 6.23 | 0.06 | 0.82 |
| Revenue CAGR (3Y) %i | -1.95 | -0.96 | -9.11 | -0.03 | -1.06 | 9.55 | -1.41 | -0.44 |
| Net income CAGR (3Y) %i | -5.60 | 49.11 | -- | 26.26 | -7.93 | -- | -- | -56.76 |
| FCF CAGR (3Y) %i | -24.41 | 24.84 | -29.95 | 51.86 | 8.37 | 69.91 | -70.21 | -21.25 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -0.58 | -1.46 | -19.70 | 3.51 | 5.60 | 6.67 |
| ROA %i | -0.06 | -0.15 | -1.72 | 0.25 | 0.68 | 0.86 |
| ROIC %i | 1.67 | 1.41 | -0.79 | 1.77 | 2.02 | 2.28 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 3.20 | 2.83 | 1.69 | 0.94 | 0.98 | 1.20 |
| FCF / sales %i | 0.38 | 0.97 | 2.53 | 2.45 | 3.01 | 3.89 |
| Current ratioi | 0.41 | 0.43 | 0.45 | 0.31 | 0.26 | 0.25 |
| Quick ratioi | 0.27 | 0.30 | 0.31 | 0.18 | 0.14 | 0.13 |
| Debt / assetsi | 65.79 | 65.23 | 66.95 | 63.37 | 63.34 | 61.34 |
| LT debt / equityi | 529.03 | 502.23 | 587.02 | 549.70 | 453.99 | 401.97 |
| Interest coveragei | 2.09 | 2.01 | 1.33 | 0.82 | 0.84 | 1.01 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- U.S. is the largest reported line at 98.31% of revenue, across 3 reported segments.
- The next-largest line, All other revenues, is a distant second at 0.94% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
U.S.98.31%
All other revenues0.94%
International Franchise0.75%
Quote time 2026-10-08 10:09:52 · For reference only, not investment advice and not tailored to your situation.